Skip to main navigation Skip to search Skip to main content

Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)

  • Bernard Chevalier
  • , Angel Cequier
  • , Dariusz Dudek
  • , Michael Haude
  • , Didier Carrie
  • , Manel Sabaté
  • , Stephan Windecker
  • , Sebastian Reith
  • , Manuel De Sousa Almeida
  • , Gianluca Campo
  • , Andres Iñiguez
  • , Yoshi Onuma
  • , Patrick W. Serruys
  • Hôpital Privé Jacques Cartier
  • Bellvitge University Hospital-IDIBELL
  • Jagiellonian University Medical College
  • Lukaskrankenhaus GmbH
  • Hôpital Rangueil
  • University of Barcelona
  • University Hospital of Psychiatry
  • University Hospital Aachen
  • Centro Hospital de Lisboa Ocidental
  • Azienda Ospedaliera Universitaria di Ferrara
  • Maria Cecilia Hospital
  • Hospital Alvaro Cunqueiro
  • Erasmus MC
  • Imperial College London

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

44 Citations (Scopus)
Original languageEnglish
Pages (from-to)1561-1564
Number of pages4
JournalEuroIntervention
Volume13
Issue number13
DOIs
Publication statusPublished - Jan 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this